Comparing N-glycan processing in mammalian cell lines to native and engineered lepidopteran insect cell lines

Area of Science:

• Biochemistry
• Molecular Biology
• Glycobiology

Background:

• Mammalian cells process N-glycans into complex structures with terminal N-acetylneuraminic acid.
• Insect cells initially follow similar N-glycan processing but diverge, producing paucimannosidic or oligomannose structures.
• Differences arise from limited expression of glycosyltransferases and sugar nucleotide metabolic enzymes in insect cell lines.

Purpose of the Study:

• To review current knowledge on N-glycan processing in lepidopteran insect cell lines.
• To summarize recent advancements in glycoengineering insect cells for complex N-glycan production.
• To highlight strategies for overcoming insect cell N-glycosylation limitations.

Main Methods:

• Genetic engineering to express missing glycosyltransferases.
• Introduction of metabolic enzymes for CMP-N-acetylneuraminic acid synthesis.
• Inhibition of N-acetylglucosaminidase to alter N-glycan processing.

Main Results:

• Engineered insect cells can produce glycoproteins with complex-type N-glycans.
• Glycoengineering addresses limitations in enzyme expression and sugar nucleotide availability.
• Strategies enable production of specific glycoforms in insect cell systems.

Conclusions:

• Insect cells can be modified to achieve mammalian-like N-glycan complexity.
• Glycoengineering offers a powerful tool for producing tailored glycoproteins.
• These advancements enhance the utility of insect cells for biopharmaceutical production.